Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Veeva Systems Inc. Class A Common Stock (NY: VEEV )

214.86 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Dec 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Veeva Systems Inc. Class A Common Stock

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Market Skids, But Bounces Off Lows; Nvidia, Pinduoduo, BYD, Jobs In Focus: Weekly Review
Major indexes broke below their 50-day lines, with Nvidia slamming chips. Pinduoduo was a big winner. 
Via Investor's Business Daily
Why Snap Shares Jumped 7%; Here Are 75 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Expert Ratings for Veeva Sys
Veeva Sys (NYSE:VEEV) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Okta, NVIDIA, MongoDB And Other Big Losers From Thursday
U.S. stocks closed mostly higher with the Dow Jones gaining around 146 points on Thursday. Here is the list of some big stocks moving lower in the previous session. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
  
Via Benzinga
Why Veeva Systems Stock Is Plunging Today
Veeva Systems Inc (NYSE: VEEV) shares are trading lower Thursday after the company reported financial results and issued topline guidance below analyst estimates. 
Via Benzinga
SVB Leerink Maintains Outperform Rating for Veeva Sys: Here's What You Need To Know
SVB Leerink has decided to maintain its Outperform rating of Veeva Sys (NYSE:VEEV) and lower its price target from $268.00 to $242.00. Shares of Veeva Sys are trading down 15.26% over the last 24... 
Via Benzinga
Medical Giant Veeva Plummets As A Key Issue Shadows Its Quarterly Beat
Veeva's sales outlook for the current quarter and the full year lagged forecasts. 
Via Investor's Business Daily
Analyst Ratings for Veeva
  Within the last quarter, Veeva Sys (NYSE:VEEV) has observed the following analyst ratings: 
Via Benzinga
The Week In Charts: Millon-Dollar Trade Missed?
Recent big winners and how we picked them, nuances of trend trading, and answering your questions. 
Via Talk Markets
Why Okta Is Trading Lower By Over 32%, Here Are 58 Stocks Moving In Thursday's Mid-Day Session
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) jumped 94.4% to $27.24. ShiftPixy announced a 1-for-100 reverse stock split. 
Via Benzinga
What Are Whales Doing With Veeva Sys
Someone with a lot of money to spend has taken a bearish stance on Veeva Sys (NYSE:VEEV). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
China News Starts The Month Of September On A Negative Note
Good Morning Everyone! Remember, bear markets can make you a lot of money - it just feels like hell at the time. 
Via Benzinga
10 Analysts Have This to Say About Veeva Sys
Analysts have provided the following ratings for Veeva Sys (NYSE:VEEV) within the last quarter: 
Via Benzinga
Snap To $29, Plus Goldman Sachs Slashes PT On This Stock By 67%
Credit Suisse cut the price target for Snap Inc. (NYSE: SNAP) from $35 to $29. Snap shares fell 0.5% to $10.83 in pre-market trading. 
Via Benzinga
Several Analysts Cut Price Targets On Veeva Systems Following Q2 Results, But This Analyst Raises PT
Veeva Systems Inc. (NYSE: VEEV) reported financial results for its second quarter and issued topline guidance below analyst estimates. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
  
Via Benzinga
NVIDIA, Hormel Foods, Rio Tinto And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
MongoDB, Inc. (NASDAQ: MDB) shares dipped 17.3% to $267.00 in pre-market trading after the company issued earnings guidance below analyst estimates. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time for another breakdown of the biggest pre-market stock movers as we cover what's moving shares on Thursday morning! 
Via InvestorPlace
Why Nutanix Is Trading Higher By 16%; Here Are 33 Stocks Moving Premarket
Gainers Bright Green Corporation (NASDAQ: BGXX) shares rose 63.8% to $2.26 in pre-market trading after gaining around 33% on Wednesday. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers 
Via Benzinga
After-Hours Action: Why Veeva Systems Stock Is Down 10%
Veeva Systems Inc (NYSE: VEEV) shares are trading lower in Wednesday's after-hours session after the company reported financial results and issued topline guidance below analyst estimates.  
Via Benzinga
Earnings Scheduled For August 31, 2022
Companies Reporting Before The Bell • Hywin Holdings (NASDAQ:HYW) is expected to report earnings for its fourth quarter. 
Via Benzinga
Needham Remains Most Optimistic On Smartsheet Citing Robust CWM Demand, And Veeva For Digitization Of Budgets
Via Benzinga
AMC Entertainment Price Target Cut By This Analyst, Plus DA Davidson Predicts $318 For Estée Lauder
DA Davidson cut the price target for The Estée Lauder Companies Inc. (NYSE: EL) from $342 to $318. Estée Lauder shares fell 0.4% to $264.29 in pre-market trading. 
Via Benzinga
Veeva Systems Stock Scores Relative Strength Rating Upgrade; Hits Key Threshold
Veeva Systems stock reached a key technical milestone, with its Relative Strength Rating, rising to 81 on Tuesday, up from 66 the day before. 
Via Investor's Business Daily
Where Veeva Stands With Analysts
  Over the past 3 months, 11 analysts have published their opinion on Veeva Sys (NYSE:VEEV) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2022
  
Via Benzinga
$100 Invested In Veeva Sys 5 Years Ago Would Be Worth This Much Today
Veeva Sys (NYSE:VEEV) has outperformed the market over the past 5 years by 15.77% on an annualized basis producing an average annual return of 25.46%. Currently, Veeva Sys has a market capitalization... 
Via Benzinga
7 Moonshot Investments Upending a $10 Trillion Industry
Gene editing is expensive at an estimated $5 billion per drug, but it could change the world in the very near future. 
Via InvestorPlace
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback